Delivery Order SPE2DB20D6037-SPE2DB25FTVW8

Award Date 6/14/25
Potential Completion Date 6/16/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $5,690.11 contract is for the delivery of 10 mg dextroamphetamine-amphetamine capsules, with a completion date of February 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, that allows the DLA to issue delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,581.84 firm fixed-price contract is for the delivery of 4,566,225,721 units of dextroamphetamine-amphetamine 10 mg capsules. The contract has an ultimate completion date of October 28, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,692.64 contract is for the delivery of dextroamphetamine-amphetamine 10 milligram tablets, with a performance period through April 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA valued up to $4,999,999 through 2025, under which this specific delivery order was...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,360.58, is for the supply of Dextroamphetamine-Amphetamine 10 mg tablets to support the medical needs of military healthcare facilities. The contract is a firm fixed-price delivery order, with a performance period extending to February 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,530.05 firm fixed-price contract is for the delivery of 4,558,698,205 dextroamphetamine-amphetamine 5 mg tablets to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 7, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,526.78 award is for the delivery of 4,558,579,566 units of the prescription drug Dextroamphetamine-Amphetamine 20 mg Capsules. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place orders for a comprehensive...
This is a $1,408.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dextroamphetamine-Amphetamine 20 mg capsules in 100-count bottles. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a $1,596.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 10 mg dextroamphetamine-amphetamine capsules, with a performance period through June 2025. This delivery order is placed under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,169.87 firm fixed-price delivery order is for the supply of 4,563,991,991 tablets of 10 mg dextroamphetamine-amphetamine, a common prescription medication. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $1,095.47, is for the supply of 4564135191 DEXTROAMP-AMPHET ER 10 MG CAP 100S. The contract is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB25FTVW8
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Dextroamphetamine-Amphetamine 15 mg capsules in 100-count packages. The total ceiling value of the contract is $3,022.29, with a period of performance through June 16, 2025. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 9/14/25, 1:05 AM